21528000

Source:http://linkedlifedata.com/resource/pubmed/id/21528000

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0085109, umls-concept:C0086418, umls-concept:C0087111, umls-concept:C0148199, umls-concept:C0162768, umls-concept:C0332237, umls-concept:C1522168, umls-concept:C1704419
pubmed:dateCreated	2011-4-29
pubmed:abstractText	The purpose of the current study was to investigate the effect of topical administration of KH906 on corneal neovascularization (NV).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-10892856, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-10937562, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-11507336, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-12360282, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-12827058, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-15277490, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-15453853, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-16044325, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-16458968, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-16508438, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-16815245, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-17027972, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-17107753, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-17355998, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-17471348, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-17562998, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-17997779, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-18025839, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-18207123, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-18246030, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-18362668, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-18439681, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-18696340, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-19936307, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-21253017, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-2431371, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-7513432, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-7539637, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-8575183, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-9672801, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-9778412, http://linkedlifedata.com/resource/pubmed/commentcorrection/21528000-9862312
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9605351
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Fluorescein, http://linkedlifedata.com/resource/pubmed/chemical/Ophthalmic Solutions, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vascular Endothelial..., http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Sodium Hydroxide, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
pubmed:status	MEDLINE
pubmed:issn	1090-0535
pubmed:author	pubmed-author:HuAndinaA, pubmed-author:HuangJuanJ, pubmed-author:JinYangY, pubmed-author:LiShiqingS, pubmed-author:LuoYanY, pubmed-author:PanJianyingJ, pubmed-author:TangShiboS, pubmed-author:TaoLiL, pubmed-author:WuJianmingJ, pubmed-author:YewDD, pubmed-author:YuHonghuaH, pubmed-author:ZhongQiQ
pubmed:issnType	Electronic
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	797-803
pubmed:meshHeading	pubmed-meshheading:21528000-Administration, Topical, pubmed-meshheading:21528000-Angiogenesis Inhibitors, pubmed-meshheading:21528000-Animals, pubmed-meshheading:21528000-Burns, Chemical, pubmed-meshheading:21528000-Cornea, pubmed-meshheading:21528000-Corneal Neovascularization, pubmed-meshheading:21528000-Fluorescein, pubmed-meshheading:21528000-Humans, pubmed-meshheading:21528000-Ophthalmic Solutions, pubmed-meshheading:21528000-Rabbits, pubmed-meshheading:21528000-Receptors, Vascular Endothelial Growth Factor, pubmed-meshheading:21528000-Recombinant Fusion Proteins, pubmed-meshheading:21528000-Sodium Hydroxide, pubmed-meshheading:21528000-Treatment Outcome, pubmed-meshheading:21528000-Vascular Endothelial Growth Factors
pubmed:year	2011
pubmed:articleTitle	KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.
pubmed:affiliation	State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center of Sun Yat-sen University, Guangzhou 510060, China.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't